nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A call for increased advocacy and universal resources to support effective nutritional interventions in the comprehensive management of patients with cirrhosis
|
Brown, Cristal |
|
|
49 |
7 |
p. |
artikel |
2 |
Analgesics use and risk of pancreatitis: Result from the UK Biobank
|
Wang, Jiayi |
|
|
49 |
7 |
p. |
artikel |
3 |
Analysis of article types of the top-100 cited articles on gastrointestinal endoscopy
|
Song, Yanqing |
|
|
49 |
7 |
p. |
artikel |
4 |
Anorectal physiotherapy in coloproctology: Guidelines of the french national society of coloproctology
|
Soudan, Damien |
|
|
49 |
7 |
p. |
artikel |
5 |
A series of Sickle cell disease-associated inflammatory bowel diseases: high prevalence of colonic involvement and primary sclerosing cholangitis
|
Kirchgesner, Julien |
|
|
49 |
7 |
p. |
artikel |
6 |
Biopsy of a hepatic small vessel neoplasm: beware of bleeding
|
Michoud, Claire |
|
|
49 |
7 |
p. |
artikel |
7 |
Cap pressure characterization and band ligation for a tiny duodenal angioectasia with acute feeding vessel bleeding mimicking a Dieulafoy lesion
|
Zimmer, Vincent |
|
|
49 |
7 |
p. |
artikel |
8 |
Chronic kidney disease in isolated core antibody positive hepatitis B patients: Risk analysis from NHANES 2017–2020 study
|
Mi, Ke |
|
|
49 |
7 |
p. |
artikel |
9 |
Circulating tumor DNA: A new tool to predict recurrence and guide treatment of colorectal cancer
|
Vo-Quang, Erwan |
|
|
49 |
7 |
p. |
artikel |
10 |
Circulating tumor DNA in peripheral blood may predict the efficacy of immune-targeted therapy in patients with hepatocellular carcinoma
|
Zheng, Su-Su |
|
|
49 |
7 |
p. |
artikel |
11 |
Contents
|
|
|
|
49 |
7 |
p. |
artikel |
12 |
Correspondence on “Evaluation of long-term changes in liver function and structure in patients exposed to SARS-CoV-2 infection: a prospective study”
|
Daungsupawong, Hinpetch |
|
|
49 |
7 |
p. |
artikel |
13 |
Does the benefit of optimal MASH treatment depend on a reduction in myosteatosis?
|
Lanthier, Nicolas |
|
|
49 |
7 |
p. |
artikel |
14 |
Editorial board
|
|
|
|
49 |
7 |
p. |
artikel |
15 |
“Evaluation of long-term changes in liver function and structure in patients exposed to SARS-CoV-2 infection: A prospective study”: Authors’ reply
|
Saifi, Erkin Saeed |
|
|
49 |
7 |
p. |
artikel |
16 |
Glucocorticoids accelerate the reduction of disease severity and biochemical parameters in drug-induced liver injury: Assess the causal relationship using the updated RUCAM scale
|
Wang, Punan |
|
|
49 |
7 |
p. |
artikel |
17 |
Hepatic organoids as a platform for liver disease modeling and the development of novel therapies
|
Luce, E. |
|
|
49 |
7 |
p. |
artikel |
18 |
Interleukin-22 ameliorates alcohol-associated liver fibrosis via Nrf2-ARE signaling: mechanistic insights and clinical correlations
|
Xu, Xiaojuan |
|
|
49 |
7 |
p. |
artikel |
19 |
Involvement of oxidative stress, lipid dysmetabolism and gut microbiol dysbiosis in oxaliplatin-induced fatty liver disease: evidence from a tree shrew model
|
Lu, Yulei |
|
|
49 |
7 |
p. |
artikel |
20 |
Liver fibrosis evaluation in patients with psychiatric diseases
|
Carrier, Paul |
|
|
49 |
7 |
p. |
artikel |
21 |
Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antivirals
|
Shengir, Mohamed |
|
|
49 |
7 |
p. |
artikel |
22 |
Natalizumab-induced autoimmune liver injury
|
Rodriguez-Martinez, Jeanete Sharay |
|
|
49 |
7 |
p. |
artikel |
23 |
Natalizumab-induced autoimmune liver injury
|
Rodriguez-Martinez, Jeanete Sharay |
|
|
49 |
7 |
p. |
artikel |
24 |
Nonalcoholic fatty liver disease and hepatocellular carcinoma
|
Liao, Kuan-Fu |
|
|
49 |
7 |
p. |
artikel |
25 |
Specific association and independent predictive value of HBV RNA in the disease progression of hepatitis B with low-level viremia
|
Xu, Liang |
|
|
49 |
7 |
p. |
artikel |
26 |
Steatosis non-invasive tests accurately predict metabolic dysfunction-associated steatotic liver disease, while fibrosis non-invasive tests fall short: Validation in U.S. adult population
|
Sualeheen, Ayesha |
|
|
49 |
7 |
p. |
artikel |
27 |
The impact of low HER2 expression on clinicopathological features and clinical outcomes in patients with metastatic gastric cancer
|
Guliyev, Murad |
|
|
49 |
7 |
p. |
artikel |
28 |
The role of tumor microenvironment in lenvatinib resistance of hepatocellular carcinoma
|
Jiang, Yao |
|
|
49 |
7 |
p. |
artikel |
29 |
The triple association of sickle cell disease, primary sclerosing cholangitis and inflammatory bowel disease (SCD-PSC-IBD): iceberg in sight
|
Marteau, Philippe |
|
|
49 |
7 |
p. |
artikel |
30 |
Trends, disparities, and outcomes of drug-induced pancreatitis in the United States: A nationwide analysis (2016–2020)
|
Tchoukeu, Guy Loic Nguefang |
|
|
49 |
7 |
p. |
artikel |
31 |
Trends in food protein-induced allergic proctocolitis (FPIAP): Mechanisms and treatment targeting gut microbiome
|
Liu, Yan |
|
|
49 |
7 |
p. |
artikel |
32 |
Unrevealing emphysematous gastritis: Insight from a comprehensive systematic review
|
Elnaggar, Mohamed |
|
|
49 |
7 |
p. |
artikel |
33 |
Utility of the fibrosis-3 index for predicting liver fibrosis 5 years after achieving sustained virological response in patients with chronic hepatitis C
|
Kariyama, Kazuya |
|
|
49 |
7 |
p. |
artikel |